Jeena Sikho Lifecare Ltd.

581.65

14 (2.5%)stock indicator image for upward trend

As on July 15, 2026
SectorNA
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap7,224 Cr
P/E Ratio214
Dividend Yield0.03 %
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

This image for unlock stock of the monthUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open566
High587
NSE SymbolJSLL
Close581.65
Low566
BSE Symbol544476
Previous Years High/Low
1 Year High849.5
3 Year High849.5
5 Year High849.5
1 Year Low492
3 Year Low65.11
5 Year Low14.11

Technicals


IndicatorsValueSignal
5-DMA582.87Bearish
10-DMA576.05Bullish
20-DMA579.26Bullish
50-DMA621.67Bearish
100-DMA630.24Bearish
200-DMA677.48Bearish

Historical Performance


1 Year
9.2%
3 Years
750.5%
5 Years
N/A
10 Years
N/A

Shareholding Pattern


%

Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


ParticularsMar-2023Mar-2022
Net Sales2,0481,466
Total Expenditure1,5891,285
Other Income2615
Operating Profit484196
Interest912
Depreciation3233
Profit Before Tax443151
Consolidated Net Profit338112
Adjusted EPS31
Compounded Sales Growth
10 Years:6.9
5 Years:6.9
3 Years:6.9
TTM:6.9
Compounded Profit Growth
10 Years:24.6
5 Years:24.6
3 Years:24.6
TTM:24.6
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:104.1
TTM:6.9
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:2.7

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


ParticularsMar-2023Mar-2022
Share Capital138101
Total Reserves1,120264
Long-Term Borrowings------
Total Non-Current Liabilities212
Other Current Liabilities139119
Short Term Borrowings---64
Total Liabilities1,506615
Capital Work in Progress1150
Long Term Loans & Advances12264
Currents Investments45---
Short Term Loans and Advances13132
Total Current Assets775215
Total Assets1,506615
Adjusted Book Value104
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 214.0, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered a strong 3-year price CAGR of 101.7%, indicating sustained price appreciation.
  • The stock carries a high beta of 1.3, implying higher volatility and elevated risk.
  • In the last financial year, the company reported an EBITDA of ₹484 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹2048 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount: ₹ 1000000
Current Value: ₹ 1068522.1
No. of Shares: 1837 (Approx)
Performance:6.9%
68522.1
NIFTY Performance: -4.5%
1 day Top Gainers
SymbolChange%
NUVOCO377.25(11%)
AEGISLOG1321.1(8%)
ATHERENERG1296.4(8%)
LTTS3508.3(7%)
INOXINDIA1964.4(6%)
1 Day Top Losers
SymbolChange%
PATANJALI347.9(-15%)
TATAELXSI3520.4(-5%)
DBREALTY116.87(-5%)
ADANIPOWER218.97(-3%)
ADANIGREEN1555.4(-3%)
GODIGIT298.65(-3%)
JSWINFRA337.35(-3%)
ZENSARTECH513.1(-3%)

Top Performing Stocks from the same sector


Ind-Swift Laboratories Ltd.

40.2%

226.82

1 Month Performance

Bafna Pharmaceuticals Ltd.

38.1%

217.12

1 Month Performance

Unichem Laboratories Ltd.

35.3%

595.1

1 Month Performance

RPG Life Sciences Ltd.

29.6%

2978.1

1 Month Performance

Wanbury Ltd.

29%

344.75

1 Month Performance

Hikal Ltd.

28.6%

240.8

1 Month Performance

Beta Drugs Ltd.

25.6%

2305

1 Month Performance

IOL Chemicals And Pharmaceuticals Ltd.

24.1%

165.7

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month